Analysis of S727-STAT3 phosphorylation in CLL cells, IL-10 production by CLL cells in response to CXCL12 stimulation, and T-cell function before and during lenalidomide treatment showed that the drug improved T-cell dysfunction (Figure 8). Here, STAT3 is linked to B-cell chronic lymphocytic leukemia.